Allorion Therapeutics

Private

Natick, MassachusettsHealthcare & Life Scienceswww.alloriontx.com

Last Round

Series B

Mar 9, 2023

Total Funding Raised

$105M

Company Overview

Allorion Therapeutics is a biopharmaceutical company that develops innovative small-molecule drugs aimed at treating cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

small molecule drugsallosteric inhibitorsoncology drugssynthetic lethalityautoimmune disease therapyclinical stage biotechprecision oncologyCDK2 inhibitordrug discovery platformtargeted therapyTYK2 inhibitordrug licensingEGFR inhibitorCDK4 inhibitorhard-to-drug targets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allorion Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Allorion Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Mar 9, 2023
Series A	Nov 24, 2021
Angel	Jul 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Fang Li

Co-Founder Chief Scientific Officer

Founding Team

Qiang Ding

Co-Founder CEO

Founding Team

wen xiong，

COO

Executive Team

Allorion Therapeutics Investors

Notable investors and investment history

Investor	Rounds
Longriver Investment Partners	Series B
Firstred Capital	Series A
TF Capital	Angel, Series A, Series B
渶策资本	Series B
IDG Capital	Series A
Elikonventure.com	Series A, Series B
LongRiver Investments	Series B

View all Investors

Allorion Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Allorion Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allorion Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNatick, Massachusetts

Employee Range32

Year Founded2020

Last FundingMar 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.